Faculty Bibliography

OBJECTIVE:Robotic head and neck surgery potentially reduces the morbidity associated with traditional open procedures. This study's goal was to employ a novel highly articulated robotic system (Flex Robotic System) for head and neck procedures, including a postauricular facelift approach thyroidectomy, submandibular gland (SMG) removal, and cervical lymphadenectomy. STUDY DESIGN/METHODS:It was hypothesized that the Medrobotics Flex Robotic System could be used for transcervical head and neck surgical procedures. METHODS:Three fresh upper body human cadavers were used. The Flex Robotic System was used to complete a thyroidectomy, neck dissection, and SMG removal on each cadaver. RESULTS:A postauricular incision and flap was manually raised. The robotic system was positioned on the right side of the cadaver's head. The system's manually controlled flexible instruments and highly shapeable, robot-assisted scope were used to perform a thyroid lobectomy. Neck dissection and SMG removal were also performed. CONCLUSIONS:Although a promising technology, the current robotic system (Intuitive Surgical Inc, Sunnyvale, California, USA) has limitations due to its rigid and large configuration, which decreases exposure and access. The new system's shapeable, computer-assisted scope seeks to reduce some of these difficulties and may be better adapted for transcervical approaches to the neck operations.

Microcystic/reticular schwannoma is a recently described variant of schwannoma with a predilection for the gastrointestinal tract, rarely involving the head/neck region. This is the first reported case involving the submandibular gland. We present a case in a 34 year old man with 4.5 cm submandibular mass. Fine needle aspiration suggested a spindle cell lesion. Frozen section evaluation raised the possibility of mucoepidermoid carcinoma. Resection showed a well circumscribed mass with a mucoid appearance. Histologic findings include a lobular architecture with fibrous septa, a lympho-plasmacytic infiltrate, and scattered lymphoid aggregates at the periphery. There are two distinct histologic patterns with solid areas of spindle cells and areas of spindle/ovoid cells with a microcystic pattern in a myxoid background. The tumor has a pushing border, with extension into adipose and adjacent parenchyma, without cytologic atypia or necrosis. Immunohistochemical stains are positive for S-100 and CD34, and negative for calponin, mammoglobin, ALK1, p63, ER, GFAP, SMA, desmin, cytokeratin 7, cytokeratin AE1/AE3, and C-Kit. Mucicarmine stain is negative. Recognition of this benign unusual variant of schwannoma is paramount for appropriate conservative treatment due to the morphologic and immunohistochemical overlap with primary salivary gland carcinomas.

OBJECTIVE: The purpose of this study was to evaluate trajectories of and predictors for changes in upper extremity (UE) function in women (n = 396) during the first year after breast cancer treatment. DESIGN: Prospective, longitudinal assessments of shoulder range of motion (ROM), grip strength, and perceived interference of function were performed before and for 1 year after surgery. Demographic, clinical, and treatment characteristics were evaluated as predictors of postoperative function. RESULTS: Women had a mean (SD) age of 54.9 (11.6) years, and 64% were white. Small but statistically significant reductions in shoulder ROM were found on the affected side over 12 months (P < 0.001). Predictors of interindividual differences in ROM at the 1-month assessment were ethnicity, neoadjuvant chemotherapy, type of surgery, axillary lymph node dissection, and preoperative ROM. Predictors of interindividual differences in changes over time in postoperative ROM were living alone, type of surgery, axillary lymph node dissection, and adjuvant chemotherapy. Declines in mean grip strength from before through 1 month after surgery were small and not clinically meaningful. Women with greater preoperative breast pain interference scores had higher postoperative interference scores at all postoperative assessments. CONCLUSION: Some of the modifiable risk factors identified in this study can be targeted for intervention to improve UE function in these women.

Patients with marker-positive central nervous system (CNS) germ cell tumors are typically monitored for tumor recurrence with both tumor markers (AFP and b-hCG) and MRI. We hypothesize that the recurrence of these tumors will always be accompanied by an elevation in tumor markers, and that surveillance MRI may not be necessary. We retrospectively identified 28 patients with CNS germ cell tumors treated at our institution that presented with an elevated serum or cerebrospinal fluid (CSF) tumor marker at the time of diagnosis. We then identified those who had a tumor recurrence after having been in remission and whether each recurrence was detected via MRI changes, elevated tumor markers, or both. Four patients suffered a tumor recurrence. Only one patient had simultaneously elevated tumor markers and MRI evidence of recurrence. Two patients had evidence of recurrence on MRI without corresponding elevations in serum or CSF tumor markers. One patient had abnormal tumor markers with no evidence of recurrence on MRI until 6 months later. We conclude that in patients with marker-positive CNS germ cell tumors who achieve complete remission, continued surveillance imaging in addition to measurement of tumor markers is indicated to detect recurrences.

OBJECTIVES: To introduce the conceptual, theoretical, and practical foundations of a novel approach to voice therapy, called conversation training therapy (CTT), which focuses exclusively on voice awareness and efficient voice production in patient-driven conversational narrative, without the use of a traditional therapeutic hierarchy. CTT is grounded in motor learning theory, focused on training target voice goals in spontaneous, conversational speech in the first session and throughout. CTT was developed by a consensus panel of expert clinical voice-specialized speech-language pathologists (SLPs) and patients with voice problems. STUDY DESIGN: This is a prospective, clinical consensus design. METHODS: A preliminary CTT approach to voice therapy was developed by the first and last authors (J.G-S. and A.I.G.) and incorporated six interchangeable tenets: clear speech, auditory/kinesthetic awareness, rapport building, negative practice, basic training gestures, and prosody. Five expert voice-specialized clinical SLPs (consensus group) were then presented CTT and a discussion ensued. Later, an informal interview by a neutral third party person occurred for further recommendations for CTT. RESULTS: The CTT approach was modified to reflect all the consensus groups' recommendations, which included the need for more detail and rationale in the program, troubleshooting suggestions, and the concern for potential challenges for novice clinicians. CONCLUSIONS: CTT is a new therapy approach based on motor learning theory, which exclusively uses patient-driven conversational narrative as the sole therapeutic stimuli. CTT is conceptually innovative because it represents an approach to voice therapy developed without the use of a traditional therapeutic hierarchy. It is also developed using input from patients with voice disorders and expert clinical providers.

BACKGROUND:Pretreatment body mass index (BMI) >25kg/m(2) is a positive prognostic factor in patients with head and neck cancer. Previous studies have not been adequately stratified by human papilloma virus (HPV) status or subsite. Our objective is to determine prognostic significance of pretreatment BMI on overall survival in HPV+ oropharyngeal squamous cell carcinoma (OPSCC). METHODS:This is a retrospective review of patients with HPV+ OPSCC treated between 8/1/2006 and 8/31/2014. Patients were stratified by BMI status (>/<25kg/m(2)). Univariate and multivariate analyses of survival were performed. RESULTS:300 patients met our inclusion/exclusion criteria. Patients with a BMI >25kg/m(2) had a longer overall survival (HR=0.49, P=0.01) as well as a longer disease-specific survival (HR=0.43, P=0.02). Overall survival remained significantly associated with high BMI on multivariate analysis (HR=0.54, P=0.04). CONCLUSIONS:Pre-treatment normal or underweight BMI status is associated with worse overall survival in HPV+ OPSCC.

OBJECTIVES/HYPOTHESIS:To illustrate detailed anatomy of the extracranial portion of the glossopharyngeal nerve in the parapharyngeal space as encountered during transoral surgery. STUDY DESIGN:Prospective cadaveric dissection. All dissections were performed transorally and confirmed with transcervical dissection. METHODS:Eight color-injected cadaveric heads (16 sides) were dissected to demonstrate the course and anatomy of the glossopharyngeal nerve. Conventional external dissections were performed to verify our anatomic measurements. Anatomical measurements of the glossopharyngeal nerve, including segments, branches in each segment, relationship with stylopharyngeus muscle, internal carotid artery, and pharyngeal branch of Vagus were recorded and analyzed. RESULTS:The glossopharyngeal nerve was separated into three segments according to the relationship with the stylopharyngeus muscle. Total lengths of the glossopharyngeal nerve are 32.6 ± 3.1 (left side) and 30.6 ± 3.7 (right side) mm, respectively. The average number of branches in the upper, middle, and lower segments is 3 (range 1-3), 4 (range 2-4), and 3 (range 1-3), respectively. The total number of branches is 8 (range 6-9). The average diameter of the main trunk of the glossopharyngeal nerve is 1.2 ± 0.3 mm, and the average diameter of the lingual branch of the glossopharyngeal nerve is approximately 0.6 ± 0.2 mm. In 75% of cases, pharyngeal branch of Vagus crosses the glossopharyngeal nerve, whereas in 25% of cases it parallels the course of the glossopharyngeal nerve to form the pharyngeal nerve plexus to innervate the pharyngeal wall. CONCLUSION:Understanding the precise and detailed anatomy of the glossopharyngeal nerve in the parapharyngeal space is important in transoral surgery for indications such as transoral robotic surgery or transoral laser microsurgery tumor resection, lingual tonsillectomy, glossopharyngeal neuralgia, glossopharyngeal nerve block, and internal carotid artery dissection. LEVEL OF EVIDENCE:N/A. Laryngoscope, 126:2010-2015, 2016.

Background - The use of bridge therapy with low-molecular-weight heparin during warfarin interruption for elective surgical and invasive diagnostic procedures leads to excess bleeding compared to interrupting warfarin alone. Other predictors of periprocedural bleeding during warfarin interruption are not well described. Aims - The purpose of this analysis was to identify predictors of major bleeding during and within 37 days after warfarin interruption for invasive procedures. Methods - BRIDGE was a double-blind, placebo controlled trial that randomized patients with atrial fibrillation requiring warfarin interruption to either bridge therapy with dalteparin 100IU/kg every 12 hours or matching placebo injections. Bleeding and thromboembolic outcomes were collected up to 37 days after the procedure. Multiple logistic regression models were used for baseline prediction of major bleeding. Time-dependent hazard models were used to add the effect of concomitant variables such as aspirin use and elevated INR values. Results - Nine hundred and fifty patients were assigned to placebo and 934 to dalteparin. Aspirin use at baseline was identified in 34.7% of the cohort (n=653) of which 60.5% (n=395) continued uninterrupted throughout the study period. The majority of procedures (89.4%) were considered low bleeding risk based on the planned surgical procedure. The median time to major bleeding was 7.0 days after surgery (interquartile range 4.0 to 18.0). Dalteparin administration was a baseline predictor of major bleeding (Odds Ratio (OR) = 2.5; 95% Confidence Interval (CI) 1.2-5.0, p=0.01), as was history of heart failure (OR=1.9; 95% CI 1.0-3.5, p=0.04) and major surgery (versus minor procedure) (OR=2.5; 95% CI 1.2-5.3, p=0.02). The current use of aspirin (OR=4.6; 95% CI 1.6-13.0, p=0.007) was significant as a time-dependent predictor of major bleeding. The presence of an elevated INR value (above 3.0) was not found to be significant when aspirin use was included in the model. Several factors known to contribute to bleeding risk during chronic anticoagulation were not found to predict bleeding around invasive procedures including age, history of hypertension, and history of gastrointestinal bleeding. The effect of history of diabetes, history of vascular disease, and gender were also evaluated but likewise these factors were not found to be significant predictors of bleeding. Conclusions - Major surgery, a history of heart failure and aspirin increase the risk of major bleeding during surgical and invasive diagnostic procedures requiring warfarin interruption. The risk and benefit of aspirin use during invasive procedures should be carefully assessed to minimize bleeding risk in this setting

Cochlear implants are neuroprosthetic devices that provide hearing to deaf patients, although outcomes are highly variable even with prolonged training and use. The central auditory system must process cochlear implant signals, but it is unclear how neural circuits adapt - or fail to adapt - to such inputs. Understanding these mechanisms is required for development of next-generation neuroprosthetics that interface with existing neural circuits and enable synaptic plasticity to improve perceptual outcomes. Here we describe a new system for cochlear implant insertion, stimulation, and behavioral training in rats. Animals were first ensured to have significant hearing loss via physiological and behavioral criteria. We developed a surgical approach for multi-channel (2-channel or 8-channel) array insertion, comparable to implantation procedures and depth in humans. Peripheral and cortical responses to stimulation were used to objectively program the implant. Animals fitted with implants learned to use them for an auditory-dependent task that assesses frequency detection and recognition, in a background of environmentally- and self-generated noise, and ceased responding appropriately to sounds when the implant was temporarily inactivated. This physiologically-calibrated and behaviorally-validated system provides a powerful opportunity to study the neural basis of neuroprosthetic device use and plasticity.